Stifel Financial’s Allergan plc AGN.PRA Stock Holding History

Stifel Financial’s Portfolio AGN.PRA Stock Details AGN.PRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-1,906	Closed	-$1.13M	–	2827
2017 Q4	$1.13M	Sell	1,906 -2,044	-52%	-$1.32M	﹤0.01%	1450
2017 Q3	$2.9M	Sell	3,950 -1,288	-25%	-$1.07M	0.01%	957
2017 Q2	$4.55M	Sell	5,238 -15	-0.3%	-$12.6K	0.02%	757
2017 Q1	$4.42M	Buy	5,253 +738	+16%	+$611K	0.02%	747
2016 Q4	$3.48M	Sell	4,515 -343	-7%	-$259K	0.01%	798
2016 Q3	$3.95M	Buy	4,858 +4,141	+578%	+$3.58M	0.02%	721
2016 Q2	$599K	Buy	+717	New	+$599K	﹤0.01%	1656

Other funds holding AGN.PRA

PWS

Peloton Wealth Strategists Indianapolis, Indiana $271M AUM 19.14% 1-Year Est. Return

Stifel Financial's AGN.PRA Position: Q1 2018 in Review

Stifel Financial sold out of Allergan plc (AGN.PRA) in Q1 2018, closing a stake of 1,906 shares — an estimated $1.13M sold.

Stifel Financial first reported a position in AGN.PRA in Q2 2016 and held it in 7 quarters. The position peaked at $4.55M in Q2 2017. 1 fund tracked by Wall St. Rank holds AGN.PRA as of Q1 2018.

Stifel Financial reported no remaining Allergan plc position as of Q1 2018 after selling out during the quarter.
Stifel Financial sold 1,906 Allergan plc shares in Q1 2018, an estimated $1.13M.
Stifel Financial first reported a position in Allergan plc in Q2 2016 and held it in 7 quarters.
Stifel Financial's Allergan plc position peaked at $4.55M in Q2 2017.
1 fund tracked by Wall St. Rank held Allergan plc as of Q1 2018.

Based on Stifel Financial's 13F filing for Q1 2018, filed 11 May 2018.